Study on H. pylori eradication

Effects of probiotic and prebiotic composition on standard regimens for H. pylori eradication

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138711231680N1

Enrollment

Registered

2010-02-06

Start date

2009-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H pylori eradication in Duodenal ulcer. Duodenal ulcer

Interventions

Intervention 1: Intervention group: 4 drug standard regimens for Iran including:amoxicillin 1 gr twice daily, metronidazole 500 mg twice daily, Omeprazole 20 mg twice daily and bismuth citrate 400mg Q

Treatment - Drugs

Placebo

Control group: 4 drug standard regimens and placebo

Intervention group: 4 drug standard regimens for Iran including:amoxicillin 1 gr twice daily, metronidazole 500 mg twice daily, Omeprazole 20 mg twice daily and bismuth citrate 400mg QID as well as p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Satisfaction to accompany, Confirmed duodenal ulcers by endoscopy, Positive RUT Exclusion criteria included previous H. pylori eradication therapy or gastric surgery, allergy to drugs, pregnancy, anti fungal treatment and incomplete drug application

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reducing signs. Timepoint: 15 ?Days. Method of measurement: Medical examination.;Helicobacter eradication. Timepoint: 1 month. Method of measurement: urea breath test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ashraf Hosseini

Kurdestan University of Medical Sciences

ashosaini@muk.ac.ir & ashosaini@yahoo.co.in+98 87 1613 1362

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026